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Mycobacterium tuberculosis (M. tuberculosis) produces a diverse range of antigenic
proteins in its dormant phase. The cytokine profiles of CD4+ T cell responses, especially
subsets other than Th1 type (non-Th1 type), against these latency-associated M.
tuberculosis antigens such as α-crystallin (Acr), heparin-binding hemagglutinin (HBHA),
and mycobacterial DNA-binding protein 1 (MDP-1) remain elusive in relation to the clinical
stage of M. tuberculosis infection. In the present study, peripheral blood mononuclear
cells (PBMCs) collected from different stages of M. tuberculosis-infected cases and
control PBMCs were stimulated with these antigens and ESAT-6/CFP-10. Cytokine
profiles of CD4+ T cells were evaluated by intracellular cytokine staining using multicolor
flow cytometry. Our results demonstrate that Th1 cytokine responses were predominant
after TB onset independent of the type of antigen stimulation. On the contrary, non-Th1
cytokine responses were preferentially induced by latency-associated M. tuberculosis
antigens, specifically IL-10 response against Acr in latentM. tuberculosis infection. From
these results, we surmise a shift in the CD4+ T cell response from mixed non-Th1 to Th1
dominant type during TB progression.
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INTRODUCTION
One-quarter of the world’s population harbors Mycobacterium
tuberculosis (M. tuberculosis) (1), however, a majority of them are
asymptomatic with the pathogen remaining dormant resulting in
a latentM. tuberculosis infection (LTBI). Only 5–10% people with
LTBI develop an active infection in their lifetime (2), which is
responsible for two billion tuberculosis (TB) cases. The primary
site of M. tuberculosis infection is almost exclusively alveolar
macrophage in the lung thus the most common clinical form is
pulmonary TB, contributing to efficient air-borne transmission.
Furthermore, chronic nature of infection delays the patients
from seeking adequate and timely health care (3). This time
lag between the gradual onset of TB to the time of diagnosis
and initiating treatment prolongs the critical period during
with the patients are being infectious and spreading aerosolic
M. tuberculosis.
Urgently needed is a diagnostic method that can detect TB
before individuals with LTBI develop symptoms and become
a source of infection. In the past two decades, IFN-γ release
assays (IGRAs) have been developed and are widely utilized in
clinical settings (4). This system quantifies the IFN-γ response
to M. tuberculosis-specific antigens, which are expressed during
active state, such as ESAT-6 and CFP-10, and detects the M.
tuberculosis infection with a higher specificity than Mantoux
skin test. However, IGRAs cannot distinguish active TB cases
from LTBI (5), and current WHO policy discourages the use
of IGRAs for the diagnosis of TB onset, especially in low- and
middle-income countries (6). In reality, the predictive value for
the development of TB from LTBI remains <10% (7).
The life cycle ofM. tuberculosis is complex due to the dormant
phase of the pathogen in the macrophages where it expresses
a diverse range of latency-associated mycobacterial antigens:
such as α-crystallin (Acr) (8), heparin-binding hemagglutinin
(HBHA) (9), andmycobacterial DNA-binding protein 1 (MDP-1)
(10). The active immune response against HBHA in LTBI has
already been reported (11), however, to our knowledge, no
previous reports described the various CD4+ T cell immune
responses of multiple latency-associated antigens simultaneously.
CD4+ T cells are important components of TB granuloma
and play a central role in restricting M. tuberculosis infection
(12). Defective CD4+ T cell response in immune-deficient
patients is reflected by the high burden of TB among HIV-
infected population (13). The subsets of the CD4+ T cells are
T-helper 1(Th1), Th2, Th17, and regulatory T cells (14–16) and
these subsets have a distinct function, which either cooperate
or interfere with each other. We believe that a comprehensive
evaluation of wide range of T cell functions would be critical for
better understanding the mechanisms involved in controllingM.
tuberculosis infection, progression of latent infection to active TB,
and the difference between latent infection and after-onset.
Abbreviations: M. tuberculosis, Mycobacterium tuberculosis; TB, Tuberculosis;
LTBI, Latent M. tuberculosis infections; Th, T-helper; IGRAs, IFN-γ release
assays; QFT, QuantiFERON TB; Acr, α-crystallin; HBHA, Heparin-binding
hemagglutinin; MDP-1, Mycobacterial DNA-binding protein 1; m, methylated.
The objective of this study is to characterize the cytokine
profile of the CD4+ T cell response to a range of M.
tuberculosis-associated antigens, including multiple latency-
associated antigens, in patients at the different clinical stages
of TB, using multi-parameter flow cytometry. We observed
that subsets other than Th1 type (non-Th1 type) CD4+ T cell
responses were preferentially induced by latency-associated M.
tuberculosis antigens in the state of LTBI.
RESULTS
Study Participants
In total, 84M. tuberculosis-infected cases and 19 healthy controls
were recruited for the study. One infected case and one control
were excluded due to inadequate blood sample, and one contact
suspect case could not be confirmed by the QuantiFERON TB
(QFT) test. Subsequently, 15 contact, 24 active, 24 on-treatment
(median duration of treatment- 1 month) and 19 after-treatment
cases (median duration of after treatment- 14months) along with
18 healthy controls were evaluated. The characteristics of the
participants are listed in Table 1.
The median age of all M. tuberculosis-infected cases was
77.5 years. Actively infected cases were older, and more likely
associated with TB risk factors such as diabetes or malignancy,
than the contact cases and controls. There was no significant
difference in the percentage of male between groups.
Th1 Cytokine Response of CD4+ T Cells to
a Range of M. tuberculosis-Associated
Antigens
Figure 1 shows Th1 cytokine (IFN-γ, IL-2, and TNF-α) responses
of CD4+ T cells to a range ofM. tuberculosis-associated antigens
in active, on-treatment, after-treatment, and contact TB cases
together with healthy controls. The level of Th1 cytokine
responses was significantly higher among TB cases than controls.
In more details, the highest IFN-γ and TNF-α responses against
ESAT-6/CFP-10 or Acr were observed in after-onset TB cases
(active, on-treatment, and after-treatment cases) (Figures 1A,B),
whereas the IFN-γ response against methylated (m) HBHA
was less apparent (Figure 1C). The level of Th1 cytokine
responses in contact cases was generally lower than after-onset
TB cases, and the difference was significant in IL-2 response
against mHBHA and mMDP-1 (Figures 1C,D), and in TNF-α
response against ESAT-6/CFP-10 and Acr (Figures 1A,B). It was
only in IFN-γ response against ESAT-6/CFP-10 and mHBHA
where the significantly higher level of cytokine responses was
detected among contact cases than controls. These findings
are comparable with results of previously published studies
on IGRAs; indicating IFN-γ response alone is unable to
detect TB clinical stage. IL-2 responses were remarkably strong
among treated TB cases (on-treatment and after-treatment cases)
(Figures 1A–D). Interestingly, a similar pattern of Th1 type
T cell responses were observed irrespective of the type of
mycobacterial antigen.
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TABLE 1 | Characteristics of the participants.
Characteristic Contact (n = 15) Active (n = 24) On-treatment (n = 24) After-treatment (n = 19) Control (n = 18)
Age-year
Median 35.0 79.0 83.0 82.0 34.0
Range 22.0–57.0 32.0–95.0 60.0–99.0 34.0–93.0 26.0–80.0
Male sex-no. (%) 8 (53.3) 16 (66.7) 15 (62.5) 10 (52.6) 10 (55.6)
TB type-no.
Pulmonary – 21 21 15 –
Extra pulmonary – 3 6 8 –
Both – 2 3 4 –
Clinical history-no. (%)
Diabetes 0 (0) 5 (21) 4 (17) 0 (0) 0 (0)
Malignancy 0 (0) 2 (8) 6 (25) 3 (16) 1 (6)
Collagen/allergy 1 (7) 2 (8) 3 (13) 1 (5) 1 (6)
Chronic resp disease 1 (7) 1 (4) 1 (4) 5 (26) 0 (0)
Other 2 (13) 12 (50) 15 (63) 12 (63) 1 (6)
Non-Th1 Cytokine Response of CD4+ T
Cells to a Range of
M. tuberculosis-Associated Antigens
Figure 2 depicts non-Th1 cytokine (IL-10, IL-13, and IL-17)
responses of CD4+ T cells to a range ofM. tuberculosis-associated
antigens in M. tuberculosis-infected cases and healthy controls.
In contrast to the Th1 cytokine responses described above,
the level of non-Th1 cytokine responses among after-onset TB
cases (active, on-treatment, and after-treatment cases) was not
significantly different (higher) than the controls except for IL-
17 responses against mHBHA (Figure 2C). A significantly higher
level of non-Th1 cytokine responses was detected among contact
cases than controls; in IL-10 responses against Acr (Figure 2B),
IL-13 responses against ESAT-6/CFP-10 (Figure 2A), IL-17
responses against Acr and mHBHA (Figures 2B,C). IL-10
responses against mMDP-1 were remarkably higher among the
contact and after-treatment cases than controls (Figure 2D).
Intriguingly the level of IL-10 responses against Acr was
significantly higher among contact cases than on-treatment and
after-treatment TB cases (Figure 2B). We used Linear regression
analysis to adjust the association between factors such as age,
diabetes, and malignancy (Table 1). Although malignancy was
associated with a difference in IL-13 responses against ESAT-
6/CFP-10, IL-13 responses were still higher among contacts
than controls after correcting for malignancy. No evidence in
the association of these factors with other significantly different
non-Th1 cytokine responses was noted.
Th1 Polyfunctional CD4+ T Cells in
Response to M. tuberculosis-Associated
Antigens
Polyfunctional T cells that produce multiple cytokines provide
more effective protective response against various infections and
has been implicated in M. tuberculosis infection as well (17).
We observed that the responses of IFN-γ and TNF-α positive
CD4+ T cells against ESAT-6/CFP-10 were appreciably higher in
after-onset TB cases (active, on-treatment, and after-treatment
cases) (Figure 3A). Interestingly, this trend was not apparent
when latency-associated M. tuberculosis antigens were applied
(Figures 3B–D).
Furthermore, we determined polyfunctional index, which
reflects the degree and variation of polyfunctionality (18). We
evaluated the responses of the polyfunctional CD4+ T cells
to M. tuberculosis-associated antigens by employing this index.
Against ESAT-6/CFP-10, index values were significantly higher
in the after-onset (active, on-treatment, and after-treatment)
TB cases than in the control cases (Figure 4A). However, no
significant difference was observed against latency-associatedM.
tuberculosis antigens (Figures 4B–D).
Interaction Between Cytokines in
Response to M. tuberculosis Antigens
We systematically analyzed the correlation of diverse cytokine
responses upon stimulation with different M. tuberculosis
antigens among M. tuberculosis-infected cases (Figures 5A–D).
As expected, strong correlation (r = 0.7241) was observed
between Th1 cytokines against ESAT-6/CFP-10 and, to lesser
extent but significant positive correlations (r = 0.2227–0.3410)
were observed between Th1 cytokines against latency-associated
antigens. Correlation between IFN-γ and IL-2 responses against
ESAT-6/CFP-10 in M. tuberculosis-infected cases, grouped
according to the clinical stage, showed that there were no
correlations in active and on-treatment cases; however, there
were moderate correlations in contact and after-treatment cases
(data not shown, r= 0.568, r= 0.623, respectively). These results
were consistent with those of the preceding study (19).
Conversely, there were significantly negative correlations
between IL-10 and Th1 cytokine responses against ESAT-6/CFP-
10 and Acr (r = −0.2476, r = −0.2303, respectively), and
also between IL-17 and Th1 cytokine responses against Acr
(r = −0.2563). In general, there were significantly positive
correlations among IL10, IL-13, and IL-17 responses. We
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FIGURE 1 | Th1 cytokine (IFN-γ, IL-2, and TNF-α) responses of CD4+ T cells to M. tuberculosis-associated antigens. Th1 cytokine responses of CD4+ T cells in M.
tuberculosis-infected cases, grouped according to the disease stage as active TB cases (n = 24), on-treatment TB cases (n = 24), after-treatment TB cases (n = 19),
and contact cases (n = 15). Responses of control cases (n = 18) are also shown. The differences between each set of samples were assessed using the
Kruskal-Wallis test and post-hoc Dunn’s Comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). The long horizontal line represents the median and the vertical line
represents the interquartile range. (A) Th1 cytokine responses to ESAT-6/CFP-10 (One data point is outside the limits in IFN-γ, and also one data point is outside the
limits in IL-2). (B) Th1 cytokine responses to Acr (Three data points are outside the limits in IL-2). (C) Th1 cytokine responses to methylated (m) HBHA (Two data
points are outside the limits in IL-2). (D) Th1 cytokine responses to mMDP-1.
observed weak or no positive correlations between IL-13 and Th1
cytokine responses, and also between IL-17 and Th1 cytokine
responses. These analyses demonstrated the independent nature
of non-Th1 cytokine responses, particularly that of IL-10, from
Th1 cytokine responses.
DISCUSSION
In the present study, we demonstrate that the level of Th1
cytokines, such as IFN-γ, IL-2, and TNF-α responses were
dominant after TB onset (active, on-treatment, and after-
treatment cases) regardless of the type of antigen. On the
contrary, the notable levels of non-Th1 cytokines, such as
IL-10, IL-13, and IL-17 responses were observed before TB
onset (contact cases), and this trend was elucidated by M.
tuberculosis latency-associated antigens, particularly apparent in
IL-10 response against Acr as summarized in Table 2. This is the
first study comprehensibly demonstrating the activation of non-
Th1 cytokines by latency-associated antigens in comparison to
ESAT-6/CFP-10 before TB onset and after TB treatment. Recently
Pandey et al. reported the presence of IL-10 response against
latency associated antigens (20), but they did not specify the type
of cells by intracellular cytokine staining, neither did they show
the responses against ESAT-6/CFP-10.
The most striking finding in the present study is that the level
of CD4+ T cell responses such as IL-10 responses against Acr was
the highest among contact cases. In fact, IL-10 responses against
Acr were significantly higher compared to on-treatment and
after-treatment TB cases. These correlations could not have been
discovered in the previously published studies. The dynamics
of IL-10 producing T cell response were independent of Th1
response (Figure 5) and these non-Th1 responses were more
efficiently induced by latency-associated antigens. IL-10 is an
anti-inflammatory cytokine, which suppresses the host immunity
(21). The production of IL-10 is positively regulated by the cell
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FIGURE 2 | Non-Th1 cytokine (IL-10, IL-13, and IL-17) responses of CD4+ T cells to M. tuberculosis-associated antigens. Non-Th1 cytokine responses of CD4+ T
cells in M. tuberculosis-infected cases, grouped according to the disease stage as active TB cases (n = 24), on-treatment TB cases (n = 24), after-treatment TB
cases (n = 19), and contact cases (n = 15). Responses of control cases (n = 18) are also shown. The differences between each set of samples were assessed using
the Kruskal-Wallis test and post-hoc Dunn’s Comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). (*) means the possible differences of preselected pairs (*P <
0.05). The long horizontal line represents the median and the vertical line represents the interquartile range. (A) Non-Th1 cytokine responses to ESAT-6/CFP-10 (Three
data points are outside the limits in IL-10, and also three data points are outside the limits in IL-13). (B) Non-Th1 cytokine responses to Acr (Three data points are
outside the limits in IL-10, and also three data points are outside the limits in IL-13). (C) Non-Th1 cytokine responses to methylated (m) HBHA. (D) Non-Th1 cytokine
responses to mMDP-1 (One data point is outside the limits in IL-10, one data point is outside the limits in IL-13, and one data point is outside the limits in IL-17).
signaling pathways, such as PI3K/AKT pathway (22). Some heat-
shock proteins including Acr, and MDP-1, which are known
to activate the PI3K/AKT pathway (23–25). M. tuberculosis
produces both Acr andMDP-1 during the latent infection (8, 10).
Especially, MDP-1 is expressed in the conditions mimicking
inner-macrophage environment, such as hypoxia. Taken together
our findings suggest that M. tuberculosis may uses tactic that
exploits IL-10 producing T cells, such as regulatory T cells,
to generate a favorable environment by impending the host
immunity from attacking it and activating infected macrophages,
allowing M. tuberculosis to survive. Because blood samples were
tested in the present study, the T regulatory type1: Tr1 (26) might
be a candidate of the IL-10 producing T cells.
Besides IL-10 responses, we also observed a significantly
high IL-17 responses among contacts compared to that among
controls, though the level was not higher than after-onset (active,
on-treatment, and after-treatment) TB cases. IL-17 triggers the
early inflammatory response via neutrophil recruitment (27). Acr
and HBHA are shown to be distributed over the M. tuberculosis
cell surface (9, 28) and HBHA acts as an adhesion molecule
for the attachment of M. tuberculosis to alveolar epithelial cells.
Thus, it is plausible that they encounter host immune system
in the very early phase of M. tuberculosis invasion. Amir et al.
reported Acr exposed dendritic cells produce IL-6 (29), which
is a key cytokine for Th17 differentiation (30). Furthermore, IL-
13 responses have also been observed among the contacts. IL-13
expression among TB cases were reported previously (31), but
the implication of this phenomenon remains unknown. Recent
studies indicated that the master regulators of CD4+ T cells–
RORγt/Foxp3 or GATA3/Foxp3 are co-expressed (32–34). These
CD4+ T cells are known to have high plasticity and can produce
multiple cytokines. GATA3/ RORγt co-expressed CD4+ T cells
are also indicated (35); thus, CD4+ T cells with high plasticity
might produce both IL-13 and IL-17. Taken together, our findings
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FIGURE 3 | Percentages of polyfunctional CD4+ T cells in IFN-γ, IL-2, and TNF-α secreting CD4+ T cells to M. tuberculosis-associated antigens in M.
tuberculosis-infected cases, grouped according to the disease stage as active TB cases (n = 24), on-treatment TB cases (n = 24), after-treatment TB cases (n = 19),
and contact cases (n = 15). Responses of control cases (n = 18) are also shown. The differences between each set of samples were assessed using the
Kruskal-Wallis test and post hoc Dunn’s Comparison test (*P < 0.05, ***P < 0.001). (*) means the possible differences of preselected pairs (*P < 0.05). The long
horizontal line represents the mean. (A) Against ESAT-6/CFP-10, three data points are outside the axis in IFN-γ, IL-2, and TNF-α positive CD4+ T cells, five data points
are outside the axis in IFN-γ and IL-2 positive CD4+ T cells, five data points are outside the axis in IFN-γ and TNF-α positive CD4+ T cells, and seven data points are
outside the axis in IL-2 and TNF-α positive CD4+ T cells. (B) Against Acr, two data points are outside the axis in IFN-γ, IL-2, and TNF-α positive CD4+ T cells, nine
data points are outside the axis in IFN-γ and IL-2 positive CD4+ T cells, four data points are outside the axis in IFN-γ and TNF-α positive CD4+ T cells, and 18 data
points are outside the axis in IL-2 and TNF-α positive CD4+ T cells. (C) Against methylated (m) HBHA, three data points are outside the axis in IFN-γ, IL-2,
(Continued)
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FIGURE 3 | and TNF-α positive CD4+ T cells, one data point is outside the axis in IFN-γ and IL-2 positive CD4+ T cells, five data points are outside the axis in IFN-γ
and TNF-α positive CD4+ T cells, and four data points are outside the axis in IL-2 and TNF-α positive CD4+ T cells. (D) Against mMDP-1, three data points are
outside the axis in IFN-γ, IL-2, and TNF-α positive CD4+ T cells, one data point is outside the axis in IFN-γ and IL-2 positive CD4+ T cells, five data points are outside
the axis in IFN-γ and TNF-α positive CD4+ T cells, and four data points are outside the axis in IL-2 and TNF-α positive CD4+ T cells.
FIGURE 4 | The values represent polyfunctional index of M. tuberculosis-associated antigens in M. tuberculosis-infected cases, grouped according to the disease
stage as active TB cases (n = 24), on-treatment TB cases (n = 24), after-treatment TB cases (n = 19), and contact cases (n = 15). The values of control cases
(n = 18) are also shown. Polyfunctional index of an object was calculated following an algorithm described previously (18). The differences between each set of
samples were assessed using the Kruskal-Wallis test and post hoc Dunn’s Comparison test (**P < 0.01, ***P < 0.001). The bar represents the median, and the vertical
line and horizontal bar represents the interquartile range. (A) Against ESAT-6/CFP-10. (B) Against Acr. (C) Against methylated (m) HBHA. (D) Against mMDP-1.
of non-Th1 cytokines led us to hypothesize that mixed types of
CD4+ T cells are induced by a different range of antigens during
LTBI or prior to TB onset.
As previously described, the strongest IFN-γ response was
observed in after-onset TB cases when stimulated with ESAT-
6/CFP-10 but we reconfirmed our previous findings that not
only IFN-γ but also IL-2 responses were dominant after TB
onset when stimulated with multiple latency-associated antigens
(36). TNF-α response was also dominant after TB onset when
stimulated with latency-associated antigens. Intriguingly the
frequency of IFN-γ responding to CD4+ T cells against ESAT-
6/CFP-10 was one log higher than that against latency-associated
antigens. This finding may reflect the fact that ESAT-6/CFP-10 is
the most abundant during active TB owing to active replication
of M. tuberculosis. ESAT-6/CFP-10 plays a pathogenic role by
perforating the cell membrane of the alveolar epithelial cells or
macrophages (37–39). The massive growth of M. tuberculosis
within the macrophages leads to cell death. One type of cell death
is apoptosis, which is also induced by ESAT-6/CFP-10 (40).
Polyfunctional T cells associated with TB have been studied
earlier (17, 41–43), but no study showed polyfunctional T cells
by latency-associated antigens. As IL-2 maintains the function
of the memory T cells (44), we found apparent responses of
the polyfunctional T cells with TB onset. We noted IFN-γ/IL-
2 double positives in the contact cases, IFN-γ/TNF-α double
positives in the active cases, and tri-functionals in the on-
treatment cases. These results were similar to those of a previous
study (17). Considering the fate of polyfunctional T cells (45),
IFN-γ/TNF-α double positives are regarded as T cells that are
optimized for effector functions; thus, Th1 cells with strong
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FIGURE 5 | The correlations between cytokines in response to M. tuberculosis antigens among M. tuberculosis-infected cases. The correlations between each
cytokine were assessed using Spearman correlation test. (A) Against ESAT-6/CFP-10. (B) Against Acr. (C) Against methylated (m) HBHA. (D) Against mMDP-1.
effector functions might be activated during early stages after
TB onset. On the contrary, none of latency-associated antigens
induced a demonstrable level of polyfunctional T cell responses
with TB onset.
Finally, we hypothesized that the pattern of CD4+ T
cell cytokine responses shift depending on the phase of M.
tuberculosis infection owing to the abundancy of latency-
associated M. tuberculosis antigen and active phase antigen
stimulation. This also suggests the potential of latency antigens
to be used for the early diagnosis of latent TB. We plotted a
dot of our study individuals categorized into four groups of in
two dimensions, IL-2 against ESAT-6/CFP-10 which represents
Th1 type response to active phase TB antigens and IL-10 against
Acr which represents non-Th1 response to latency-associated
TB antigens in Figure 6. Controls cumulate in the left lower
quadrant whereas active cases in the right upper quadrant. One
of the striking findings is that after treatment cases clearly
cumulate in the left upper quadrant. They were dissociated from
active cases by IL-10 responses against Acr, while their IL-2
responses remained as high. This may reflect the living status
of M. tuberculosis as the bacteria may exploit the stimulation of
regulatory T cells as their survival strategy as discussed above.
Although it is not apparent, contact cases tend to cumulate in the
right lower quadrant. There could have been more contact cases
in this quadrant, if they had not been selected by QFT positivity.
On the other hand, there was one control in this quadrant. This
individual might have been infected with M. tuberculosis. This
raises a question whether the definition of contacts and controls
determined by QFT alone is appropriate.
There are several limitations in the present study design. First,
this present study was done in a cross-sectional manner. In order
to reveal the shift in CD4+ T cell profile, we need to follow the
patients in longitudinal manner. Second, we selected contacts
from controls based on QFT results. As mentioned above, our
contacts do not present the whole latent infections, which should
include QFT negative cases. For further investigation, we need
to design a study that takes account of the histories of close
contacts or the endemic areas rather than QFT positively. Third,
there was significant difference in the median age of each clinical
case, especially between controls/contacts and other stages. We
found no evidence of association of age by using linear regression
analysis, however, possibility that aging has some influence
on CD4+ T cells cannot be ignored completely. In Japan, M.
tuberculosis non-infected cases or non-disease cases are limited
to young generation. We carried out this study in the limited
facilities of Japan and it was difficult to match the age in each
clinical case. Lastly, we did not exclude TB patients with diabetes,
which might have impaired immune responses. However, we
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TABLE 2 | Summary of cytokine responses.
Contact Active On Tx After Tx
(A) Compared with control
ESAT-6/
CFP-10
IFN-γ**
IL-13*
IFN-γ***
IL-2***
TNF-α***
IFN-γ***
IL-2***
TNF-α***
IFN-γ***
IL-2***
Acr IL-10***
IL-17*
IFN-γ***
IL-2*
TNF-α***
IL-10**
IFN-γ***
IL-2***
TNF-α***
IFN-γ**
IL-2**
TNF-α**
mHBHA IFN-γ*
IL-17**
IL-2**
IL-17***
IFN-γ***
IL-2***
IL-17**
IFN-γ**
IL-2***
IL-17**
mMDP-1 IL-10(*) IL-2** IL-2**
IL-10(*)
(B) Compared with contact
ESAT-6/
CFP-10
TNF-α*
Acr TNF-α** TNF-α**
IL-10**
IL-10**
mHBHA IL-2*
mMDP-1 IL-2**
The differences between each set of samples were assessed using the Kruskal-Wallis test
and post hoc Dunn’s Comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). (*) means
the possible differences of preselected pairs (*P < 0.05).
FIGURE 6 | Scatter plot between IL-2 response against ESAT-6/CFP-10 and
IL-10 response against Acr in M. tuberculosis-infected cases and control
cases (n = 100, Two points are outside axis limits). This scatter plot was
divided into four quadrates, and each quadrate was numbered from I to IV.
Most of controls are in No. I quadrate. Contacts and actives are in No. II and
No. III quadrates, in particular, actives are noticeable in No. III quadrate.
After-treatments are noticeable in No. IV quadrate.
prioritized recruiting a larger sample size because their diabetes
was well-controlled and such effect was minimized. For our
future study, recruiting more patients from other facilities would
be required to match the ages.
In conclusion, non-Th1 cell responses to M. tuberculosis are
preferentially induced by latency-associated antigens in LTBI.
These findings raise a possibility of developing a new generation
of cell-mediated immune assay to distinguish active TB infection
from LTBI and/or cured TB, and bringing a new tool for
improving management ofM. tuberculosis infection.
MATERIALS AND METHODS
Study Participants
M. tuberculosis-infected cases were recruited from four different
hospitals in Japan, National Hospital Organization Higashi-saga
Hospital, National Hospital Organization Nagasaki Kawatana
Medical Center, TagamiHospital (Nagasaki, Japan), andNagasaki
University Hospital.
Healthy controls with no history of TB were recruited at
Nagasaki University.
All the blood samples included in this study were obtained
with informed consent and with ethical approval from the
Institute of Tropical Medicine Nagasaki University Joint
Ethics Committee.
The M. tuberculosis-infected cases were divided into four
clinical stages, active, on-treatment, after-treatment, and contact.
The M. tuberculosis-infected cases without contact cases were
clinically diagnosed and confirmed by using smear PCR,
culture, or course of treatment. Active cases were at the point
from the diagnosis to within 10 days treatment. On-treatment
cases were at the point after 10 days treatment. The QFT
test (QuantiFERON R©TB-GOLD In-Tube; QIAGEN, Hilden,
Germany) positive cases without any symptoms or history of
TB were regarded as contact cases. The QFT test intermediate
cases that had a history of contact with TB patients were also
regarded as contact cases. The QFT test negative cases without
any symptoms were considered as healthy controls.
Reagents
ESAT-6, CFP-10, Acr, HBHA, and MDP-1 were recombinant
protein products from E. coli. The synthesis of these proteins was
carried out as described previously (36). Chemical methylation in
HBHA and MDP-1 was also performed because we ascertained
the necessity of methylation previously (36).
The following fluorescently-labeled monoclonal antibodies
were used in this study: anti-CD3-APC-Cy7 (HIT3a), anti-
IFN-γ-PE-Cy7 (4S.B3), anti-IL-10-PE (JES3-9D7), anti-IL-17-
Alexa Fluor 700 (BL168), anti-TNF-α-PerCP-Cy5.5 (MAb11)
(Biolegend, San Diego, CA, USA), Anti-CD4-Pacific Blue
(OKT4), anti-IL-2-APC (MQ1-17H12), and anti-IL-13- FITC
(PVM13-1) (eBioscience, San Diego, CA, USA). Cell viability
was assessed using a LIVE/DEAD kit (Invitrogen, Carlsbad,
CA, USA). FcR blocking reagent was purchased from MBL
(Nagoya, Japan). CD28/CD49d co-stimulator was purchased
from BD Bioscience (San Jose, CA, USA). Brefeldin-A (BFA)
and Monensin sodium salt were purchased from Sigma-Aldrich
(St. Louis, MO, USA) and Wako Junyaku Co. Ltd (Tokyo,
Japan), respectively.
In vitro Culture
Peripheral blood mononuclear cells (PBMCs) isolation and
culture were performed as described previously (36). The PBMCs
were isolated within 6 h after taking heparinized blood samples.
Antigen concentrations were as follows: ESAT-6 and CFP-10
(0.75µg/ml each), Acr (0.8µg/ml), mHBHA (1.7µg/ml), and
mMDP-1 (6µg/ml). Cultures with no antigen (medium only)
were also included. All antigen stimulations were performed
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in the presence of CD28/CD49d co-stimulator (0.5µg/ml)
and golgi-blocker: BFA (1µg/ml) and Monensin (0.5µM).
Cell incubation was overnight (14–16 h) at 37◦C in a 5%
CO2 incubator.
Flow Cytometry
Cell surface staining, permeabilizing, and intracellular cytokine
staining were performed as described previously (36). At surface
staining stage, 30% goat serum containing anti-CD3, anti-CD4,
FcR blocking reagent, and LIVE/DEAD reagent were added. At
intracellular cytokine staining stage, anti-cytokine monoclonal
antibody cocktail containing IFN-γ, IL-2, IL-10, IL-13, IL-
17, TNF-α, and FcR blocking reagent were added. Cells were
acquired using Gallios (Beckman Coulter, Brea, CA, USA). Flow
cytometry data were analyzed using FlowJo software, version
8.8.7 (TreeStar, San Carlos, CA, USA). Gating strategy for flow
cytometric analysis are shown in Supplementary Figure 1.
Polyfunctional Index
Polyfunctional index of an object was calculated following an
algorithm described previously (18). Then, group medians of
these indexes were compared.
Statistical Analysis
Group medians and distributions were analyzed using Kruskal-
Wallis test with post-hoc Dunn’s Comparison test. Associations
were adjusted by using Linear regression analysis. Correlations
were analyzed using Spearman correlation test. Analysis were
performed with GraphPad Prism software, version 5 and 7 (San
Diego, CA, USA) and STATA software, version 13 (College
station, TX, USA). The threshold for significance was P < 0.05.
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